TiCARos - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 4

An End-to-End Solution to Accelerate CAR-T Cell Development from Concept to Clinic

CAR-T cell therapies have demonstrated tremendous success in relapsed or refractory haematological malignancies. Now therapeutics companies and academics alike are ra...

9 December 2021 Volume 4 Issue 4 cancer | CAR-T cell

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

An End-to-End Solution to Accelerate CAR-T Cell Development from Concept to Clinic

International Biopharmaceutical Industry